Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N412968-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,691.90 | |
N412968-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,761.90 | |
N412968-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,821.90 | |
N412968-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $319.90 | |
N412968-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,171.90 | |
N412968-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,481.90 |
Specifications & Purity | Moligand™, ≥98% |
---|---|
Biochemical and Physiological Mechanisms | NCGC607 is a a noninhibitory chaperone of glucocerebrosidase (GCase). |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Mechanism of action | glucosylceramidase beta |
Product Description | Information NCGC607 is a a noninhibitory chaperone of glucocerebrosidase (GCase). |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-[2-(4-iodoanilino)-2-oxoethoxy]-N-[2-(N-methylanilino)-2-oxoethyl]benzamide |
---|---|
INCHI | InChI=1S/C24H22IN3O4/c1-28(19-7-3-2-4-8-19)23(30)15-26-24(31)20-9-5-6-10-21(20)32-16-22(29)27-18-13-11-17(25)12-14-18/h2-14H,15-16H2,1H3,(H,26,31)(H,27,29) |
InChi Key | HFVDMJQQAKLUSN-UHFFFAOYSA-N |
Canonical SMILES | CN(C1=CC=CC=C1)C(=O)CNC(=O)C2=CC=CC=C2OCC(=O)NC3=CC=C(C=C3)I |
Isomeric SMILES | CN(C1=CC=CC=C1)C(=O)CNC(=O)C2=CC=CC=C2OCC(=O)NC3=CC=C(C=C3)I |
PubChem CID | 46943210 |
Molecular Weight | 543.35 |
PubChem CID | 46943210 |
---|---|
CAS Registry No. | 1462267-07-7 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F2420278 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420279 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420280 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420281 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420282 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420283 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420284 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420285 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420286 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420287 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420288 | Certificate of Analysis | Mar 14, 2024 | N412968 |
F2420289 | Certificate of Analysis | Mar 14, 2024 | N412968 |
Sensitivity | 对光线敏感 |
---|
1. Aflaki E, Borger DK, Moaven N, Stubblefield BK, Rogers SA, Patnaik S, Schoenen FJ, Westbroek W, Zheng W, Sullivan P et al.. (2016) A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.. J Neurosci, 36 (28): (7441-52). [PMID:27413154] [10.1021/op500134e] |
2. Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, Pastores GM, Rubinsztein DC, Nixon RA, Duchen MR et al.. (2018) Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.. Nat Rev Drug Discov, 17 (9): (660-688). [PMID:30116051] [10.1021/op500134e] |